Article
Illuminating HLA-DPA1 and HSH2D as Potential Prognostic Biomarkers by Weighted Gene Co-Expression Network Analysis for NRAS-Mutant Skin Cutaneous Melanoma
2023-12-06
Abstract excerpt
<h4>Background: </h4> NRAS-mutant skin cutaneous melanoma (NRAS-MT SKCM) poses clinical challenges due to its aggressive progression and unfavorable outcomes compared to other subtypes. NRAS mutations, present in around 26% of cases, play a significant role in cutaneous melanoma. However, targeted therapies tailored to NRAS mutations are currently lacking, highlighting an unmet need. Our study aimed to identify hu...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 83200ea6-65fa-5ca1-a8e5-55ced4b5bd50
- DOI
- 10.21203/rs.3.rs-3704755/v1
